Reisa Sperling, MD
Affiliations: | Harvard University, Cambridge, MA, United States |
Google:
"Reisa Sperling"Mean distance: 17.12 (cluster 29) | S | N | B | C | P |
Children
Sign in to add traineeKim Celone | research assistant | Boston University&Harvard Medical School | |
Elizabeth F. Chua | research assistant | Brooklyn College (CUNY) | |
Federico d'Oleire Uquillas | research assistant | 2016- | |
Willem Huijbers | post-doc | Harvard University Medical School, Brigham & Women's Hospital | |
Heidi Jacobs | post-doc | ||
Bradford C. Dickerson | post-doc | 2001-2008 |
Collaborators
Sign in to add collaboratorPaul S. Aisen | collaborator | ||
Amirah K Anderson | collaborator | 2020- | Brigham & Women's Hospital, Harvard Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Aisen P, Bateman RJ, Crowther D, et al. (2024) The case for regulatory approval of amyloid-lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Gunasekaran TI, Meena D, Lee AJ, et al. (2024) Genome-wide scan of Flortaucipir PET levels finds associated with cerebral tau deposition. Medrxiv : the Preprint Server For Health Sciences |
Lam AD, Thibault EG, Mayblyum DV, et al. (2024) Association of Seizure Foci and Location of Tau and Amyloid Deposition and Brain Atrophy in Patients With Alzheimer Disease and Seizures. Neurology. 103: e209920 |
Nho K, Risacher SL, Apostolova LG, et al. (2024) CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET. Nature Communications. 15: 8251 |
Stankeviciute L, Chhatwal JP, Levin R, et al. (2024) Amyloid beta-independent sleep markers associated with early regional tau burden and cortical thinning. Alzheimer's & Dementia (Amsterdam, Netherlands). 16: e12616 |
Schultz SA, Liu L, Schultz AP, et al. (2024) γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology |
Engels-Domínguez N, Riphagen JM, Van Egroo M, et al. (2024) Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals. Annals of Neurology |
Farrell ME, Thibault EG, Becker JA, et al. (2024) Spatial extent as a sensitive amyloid-PET metric in preclinical Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Boyle R, Townsend DL, Klinger HM, et al. (2024) Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration. Alzheimer's Research & Therapy. 16: 148 |
Jack CR, Andrews JS, Beach TG, et al. (2024) Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |